Smart Labels Market

Market Size

The global smart labels market, valued at USD 5.4 billion in 2025, is projected to reach USD 6.4 billion in 2026 and USD 24.0 billion by 2035, with a 16% CAGR during the forecast period 2026 to 2035.

Market Report: Key Takeaways

Market Size & Trends

• In terms of type of technology, the RFID segment holds the highest share (75%) of the market.
• With regards to type of packaging, the primary packaging segment dominates the global market with 95% market share.
• Based on the type of primary packaging, the syringes reagents hold the largest market share (nearly 40%) in 2026.
• With respect to type of secondary packaging, the cartons dominate the global market with 50% market share.
• In terms of geographical regions, Europe captures the majority of the market share, and Middle East and North Africa is likely to grow at a faster pace in the near future.

Market Overview

Smart labels, also known as tags, offer several benefits, such as supply chain analytics for tracking and tracing the products, and tamper proofing, discouraging counterfeiters from packaging fake drugs. In this context, it is worth mentioning that smart labelling technology is likely to save $0.8-1.5 million per year per company, through their applications in inventory management.

As per a report published by the World Health Organization (WHO), 20% of counterfeit pharmaceuticals include an incorrect amount of the active ingredient, while 30% of the counterfeit drugs contain no active ingredient at all. Such illegal practices are likely to endanger the lives of the patients, as well as tarnish the developer company's reputation.

In order to overcome the above listed concerns, label service providers have strengthened the ongoing labelling practices and are shifting towards smart labelling technologies, which are a part of the intelligent packaging market.

The requirement for enhancement of supply chain transparency, inventory management, rise of E-commerce and digital transformation have spurred the demand for smart labels to uphold the product quality as well as consumer trust. Further, advancements in technologies like NFC and RFID have significantly improved the capabilities of smart labels, making them more versatile and cost-effective.

Market Trends

• Integration with IoT and Cloud Services: The market players are focusing on the integration of smart labels with internet of things and cloud-based platforms / services. This integration will provide real-time data on condition, location of pharmaceutical products and environment factors (temperature and humidity) throughout the supply chain.
• Advanced Sensor Integration for Cold Chain Monitoring: Market players are undertaking initiatives to develop advanced sensors and integrate it with smart labels for cold chain monitoring. The integration of smart sensors, such as time and temperature indicators are crucial for cold-chain monitoring in pharmaceutical industries to maintain product integrity and viability. In addition, the anti-counterfeit security and flexible sensors or battery-free sensor labels will be the prime focus of the industrial players to enhance prevent drug counterfeiting and product authenticity.
• Digital Smart Labels for Pharma: Pharmaceutical companies are exploring digital display labels that overcome the challenges with production timelines for paper labels. Digital labels have the capability to provide real-time updates and options of multiple languages. Merck and Johnson & Johnson collaborated for development of digital display labels which is planned to be presented at AIPIA & AWA Smart Packaging Congress to be held in June 2025.
• Technological Advancements to Fuel Innovation: The smart labels manufacturers have undertaken various initiatives so as to propel the ongoing technological advancements in this domain, which includes enhanced RFID tags (enabling real-time tracking and inventory management in various industries), advancement in NFC technology (its ability to enable direct interaction between products and smartphones without requiring additional apps), and sensing labels (enabling real-time data collection on environmental conditions like temperature and humidity).

Industry Experts

Companies engaged in the smart labels domain are actively developing solutions to enable a connected pharma supply chain. In this context, Venu Gutlapalli (Chief Executive Officer, Tag-N-Trac), while entering into a collaboration with Identiv for its advanced BLE smart labels in April 2025, states, “Cold chain visibility is one of the most complex and vital challenges in pharmaceutical distribution and logistics. Together with Identiv, we’re delivering a comprehensive digital solution that gives pharmaceutical companies the confidence and data intelligence to manage temperature-sensitive products safely, efficiently, and in full compliance.”

Market Share Insights

Market Share by Type of Technology

• The technology segment in the global market for smart labels for pharmaceutical and healthcare industry is further divided into various sub-segments namely, RFID, NFC and other technologies. In 2026, the RFID segment captures the majority (75%) of the global market and this segment is likely to grow at the highest CAGR during the forecast period.
• This is the result of their ability to allow quick and efficient data capture and eliminating the requirement for direct line-of-sight scanning. Notably, RFID labels have wider applicability among various industries in providing enhanced efficiency, accuracy and security benefits.
• These RFID tags are classified as passive RFID tags or active RFID tags. These tags are further classified on the type of RFID frequency band. The most popularly offered tags are the ultra-high frequency / UHF RFID labels, with nearly 68% of the manufacturers offering this product for pharmaceutical applications.

Market Share by Type of Primary Packaging: Smart Labels for Syringes in Pharmaceuticals to Hold the Largest Share

• In 2026, the syringes segment (40%) dominates the market, and this segment is likely to grow at the highest CAGR during the forecast period.
• This is due to their inherent advantages in ease of administration, sterility assurance, and convenience for both healthcare professionals and patients. Prefilled syringes minimize dosage errors, limit preparation time, and offer a single-use format, enhancing safety and accuracy.
• In January 2025, Avery Dennison introduced its RFID tag for prefilled syringes, BD iDFill, which was developed in collaboration with Becton Dickinson. RFID tags are embedded into the rigid needle shield of the syringe and carry the container’s unique identifier (CUID). Other companies like Schreiner MediPharm, Schott Pharma and NP Plastibell have also developed smart tags for syringes.

Market Share by Geographical Regions: Latin America to Propel in the Smart Labels Sector in the Coming Years

• According to our projections, Europe is likely to capture the majority (35%) of the overall smart labels market share for pharmaceutical and healthcare industry in the current market, and this trend is unlikely to change in the future.
• It is worth highlighting that the market in Latin America is likely to grow at a relatively higher CAGR (26%), during the forecast period. This is a result of the increasing E-commerce activities and the modernization of retail operations. The region is witnessing significant investments in smart label manufacturing facilities and technological infrastructure.

Market Insights

Competitive Landscape of Smart Labels Manufacturers

The current market landscape features over 90 manufacturers including very large, large, mid-sized and small companies. These manufacturers have the necessary expertise to provide based on various technologies, such as RFID, NFC (near field communication) and other advanced technologies that enable tracking of products throughout the supply chain.

Notably, majority of the smart labels’ technology providers offer services related to RFID technology, followed by the providers offering services for Internet of Things (IoT). In addition to this, over 40% of the smart labels’ technology providers in this domain are based in North America, because this region offers supportive regulatory compliance and houses well-established facilities to carry out extensive research and development processes.

Segment Analysis: RFID Smart Labels Adoption in Pharmaceutical Industry

Over 80 manufacturers are developing RFID smart labels for a wide range of applications. RFID tag manufacturers are working on developing smaller RFID labels which can allow item level track and trace within the pharmaceutical supply chain. In February 2022, Avery Dennison Smartrac launched its Minidose U9 RAIN RFID inlay, which claims to be the smallest smart label in the market for pharmaceutical applications.

Pfizer was the first company to use an RFID tag for its drug Viagra. Pharmaceutical companies such as Hanmi Pharmaceutical are using RAIN RFID tags from Impinj containing an Impinj Monza tag chip to track each product through the supply chain. As the pharmaceutical industry continues to adopt smarter technologies, IoT based smart labels are becoming widely accepted as they enable more functionality than regular smart labels. The market size for the RFID segment is likely to grow at a relatively higher CAGR of 16.0% during the forecast period.

Market Segmentation Insights

Frequently Asked Questions